Search alternatives:
"significant increases release" » "significant increase release" (Expand Search), "significantly increased release" (Expand Search), "significant decrease release" (Expand Search), "significant increased release" (Expand Search), "significant increased reliance" (Expand Search), "significant increases reversal" (Expand Search)
"significant changes decrease" » "significant larger decrease" (Expand Search), "significant change increases" (Expand Search), "significant largest decrease" (Expand Search)
"significant increases release" » "significant increase release" (Expand Search), "significantly increased release" (Expand Search), "significant decrease release" (Expand Search), "significant increased release" (Expand Search), "significant increased reliance" (Expand Search), "significant increases reversal" (Expand Search)
"significant changes decrease" » "significant larger decrease" (Expand Search), "significant change increases" (Expand Search), "significant largest decrease" (Expand Search)
-
1
Image_1_In vitro evaluation of iron oxide nanoparticle-induced thromboinflammatory response using a combined human whole blood and endothelial cell model.pdf
Published 2023“…Furthermore, IONPs mediated a strong thromboinflammatory response, as seen by the significantly increased release of 21 of the 27 analyzed cytokines (p<0.05). …”
-
2
Image_2_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.tif
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
3
Image_4_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.tif
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
4
Image_1_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.tif
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
5
Table_1_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.docx
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
6
Image_3_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.tif
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
7
Table_2_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.docx
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
8
Qsp1 regulation of binding of Cqs2, Nrg1, and Liv3 to promoters correlates with a change in expression.
Published 2020“…E) Overlap between gene sets that are differentially bound by all three transcription factors (Liv3, Cqs2, and Nrg1) in the <i>qsp1Δ</i> mutant compared to wild type and genes that are significantly changed, decreased, or increased in the <i>qsp1Δ</i> mutant over wild type.…”